# OnCo record paper-dess-black-race-prostate-mortality-jama-oncol-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-dess-black-race-prostate-mortality-jama-oncol-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-dess-black-race-prostate-mortality-jama-oncol-2019" ;
  schema:name "Association of Black race with prostate cancer-specific and other-cause mortality"@en ;
  schema:alternateName "Dess 2019"@en, "Black race prostate cancer mortality equal access"@en ;
  schema:description "Black men in the United States are more likely to die of prostate cancer. This study looked at registry data, an equal-access health system and randomised trials together, and found that once treatment and access were equal, the difference in prostate cancer deaths largely disappeared. The difference in dying of everything else did not."@en ;
  schema:url <https://onco.cc/key-papers/paper-dess-black-race-prostate-mortality-jama-oncol-2019/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2019.0826>, <https://pubmed.ncbi.nlm.nih.gov/31120534/> ;
  onco:tag "prostate-evidence" ;
  schema:sameAs <https://doi.org/10.1001/jamaoncol.2019.0826> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Dess RT, Hartman HE, Mahal BA, et al." ;
  onco:related <https://onco.cc/key-papers/paper-conti-trans-ancestry-gwas-prostate-nat-genet-2021/>, <https://onco.cc/key-papers/paper-uspstf-prostate-screening-jama-2018/>, <https://onco.cc/ideas/idea-acc-cardiometabolic-clinic-hormone-therapy/>, <https://onco.cc/roadmaps/prostate-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-intermediate-risk/>, <https://onco.cc/cancers/prostate-high-risk/> ;
  onco:sections <https://onco.cc/fronts/early-detection/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:terms <https://onco.cc/terms/screening/>, <https://onco.cc/terms/hazard-ratio/>, <https://onco.cc/terms/other-cause-mortality/>, <https://onco.cc/terms/polygenic-risk-score/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-trial-diversity/>, <https://onco.cc/bottlenecks/b-care-fragmentation/>, <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-aging-comorbidity/> ;
  onco:journals <https://onco.cc/journals/jama-oncology/> .